Cleared Traditional

K061144 - DEPUY CMW 2 AND CMW 3 GENTAMICIN BONE CEMENT (FDA 510(k) Clearance)

Jun 2006
Decision
44d
Days
Class 2
Risk

K061144 is an FDA 510(k) clearance for the DEPUY CMW 2 AND CMW 3 GENTAMICIN BONE CEMENT. This device is classified as a Bone Cement, Antibiotic (Class II - Special Controls, product code MBB).

Submitted by DePuy Orthopaedics, Inc. (Warsaw, US). The FDA issued a Cleared decision on June 8, 2006, 44 days after receiving the submission on April 25, 2006.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3027.

Submission Details

510(k) Number K061144 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 2006
Decision Date June 08, 2006
Days to Decision 44 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MBB - Bone Cement, Antibiotic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3027